Kiromic Announces the Filing of Key European Patents for Its Chimeric PD-1 (chPD1) Target
The Pharma Data
JANUARY 4, 2021
.” Kiromic’s DIAMOND is big data science meeting target identification, dramatically compressing man-years and billions of drug development dollars to develop a live drug. This press release contains forward-looking statements that involve substantial risks and uncertainties. Forward-Looking Statements.
Let's personalize your content